Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-23

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022.

A review will be made from the medical records, radiological imaging, and histological data of these patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

NCT06486506

Bone Tumor Bone Cancer

RECRUITING

Pediatric Oncological Orthopaedic Reconstruction

NCT06522165

Bone Tumor Bone Cancer

ACTIVE_NOT_RECRUITING

Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study

NCT06189079

Bone Metastases

RECRUITING

An Observational Study of Local Relapse After High Grade Osteosarcoma

NCT06017518

Osteosarcoma

RECRUITING

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

NCT04758000

Osteosarcoma Ewing Sarcoma

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Metastases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Male and female patients affected by bone metastases derived from carcinoma, treated at Rizzoli Orthopaedic Institute from 01/01/2010 to 31/12/2022

Analysis

Intervention Type OTHER

Analysis and review of imaging and clinical data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Analysis

Analysis and review of imaging and clinical data

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
* Availability of imaging and clinical data
* Availability of at least one follow-up during the last 12 months form diagnosis